ASCO® 2024 Insights: "PROs of the MEDISARC Study (AIO-STS-0415) - Durvalumab & Tremelimumab vs. Doxorubicin in Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma"

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "PROs of the MEDISARC Study (AIO-STS-0415) - Durvalumab & Tremelimumab vs. Doxorubicin in Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Viktor Grünwald

0 views

June 12, 2024

Comments 1

2024 ASCO® Annual Meeting Insights Hub: Sarcoma Videos

07:57

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Efficacy of Nirogacestat in Patients With…

Feat. B. Vincenzi

16:37

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Highlights in Sarcomas

Feat. R. Jones

02:27

ecancer

ASCO® 2024 Insights: "Monitoring Ovarian Function in DeFi Study…

Feat. E. Loggers

View All

2024 Update in Sarcomas

Feat. D. Portnoy

22:27

2024 ASCO® Annual Meeting Insights Hub

Developmental Therapeutics Highlights From ASCO® 2024

Feat. G. Sonpavde

19:40

Warren Chow

Gastrointestinal Stromal Tumors (GIST) and Resistance Mutations

18:46

OncoAlert

Systemic Therapies for Uterine Leiomyosarcoma

Feat. I. Ray-Coquard

25:23

Andrea Napolitano

NCCN Clinical Practice Guidelines for Treating GIST

21:12

ISCO - International School of Clinical Oncology

What Is New in Treatment of Soft Tissue and Bone Sarcoma

Feat. S. Stacchiotti

25:02

Total Health

Sarcoma 101: Multidisciplinary Approach, Therapies, and Future Direc…

Feat. B. Wilky

15:45

i3 Health

Multidisciplinary Management of Advanced Soft Tissue Sarcoma

Feat. S. Patel, B. Ruben, K. Polson

10:55

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Novel Combinations in Sarcomas"

Feat. R. Jones

16:37

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Highlights in Sarcomas

Feat. R. Jones

22:21

Miami Cancer Institute Precision Oncology Symposium

Divide and Conquer Sarcomas Through Precision Oncology

Feat. N. Somaiah

18:44

2023 West Oncology Conference

2023 West Oncology Conference: Soft Tissue Sarcoma Updates

Feat. B. Van Tine

10:48

Insights from 2024 ASCO® GI Annual Meeting

INSIGHT: A Phase 3 Study of Ripretinib vs. Sunitinib in Pts With Adv…

Feat. J. Zalcberg

09:02

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Phase II Basket Trial of Dual Anti-CTLA…

Feat. Y. Chae

56:31

Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Fred Hutchinson Cancer Center Sarcoma Updates

Feat. M. Wagner

07:29

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Randomized Phase 2 Trial in Metastatic So…

Feat. B. Van Tine

12:08

University of Miami Sylvester Comprehensive Cancer Center

Active Surveillance vs. Active Treatment for Desmoid Tumor: An Exper…

Feat. G. D'Amato

07:00

Insights from 2024 ESMO Sarcoma and Rare Cancers Congress

ctDNA Analysis From INTRIGUE Study: Updated OS & Safety With Rip…

Feat. J. Blay

11:03

Insights from 2024 ASCO® GI Annual Meeting

Final Analyses From INTRIGUE: OS & Long-Term Safety With Ripreti…

Feat. J. Zalcberg

13:53

Robin Jones

Login

Login

Join VuMedi

ASCO® 2024 Insights: "PROs of the MEDISARC Study (AIO-STS-0415) - Durvalumab & Tremelimumab vs. Doxorubicin in Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma"

2024 ASCO® Annual Meeting Insights Hub: Sarcoma Videos

Recommended